Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.

Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after ...

A Shreveport-Bossier City musician is working tirelessly to better the quality of life for people like her sons, some of whom ...

Researchers studied the efficacy of hydroxyurea at reducing stroke risk in sickle cell anemia, the most common and severe ...

MOROGORO: The provision of screening services for sickle cell Disease and diabetes type one in newborns has continued to be ...

A young man from Laurelton is the first New Yorker with sickle cell disease to receive Lyfgenia, a life-changing gene therapy treatment that has wiped away the debilitating illness, The Post first ...

Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), today announced its ...

Columnist Oluwatosin Adesoye shares how she processes her emotions when she's feeling guilty about the care she needs due to sickle cell.

Zydus Lifesciences Ltd on Wednesday (March 12) the company's venture capital arm Zynext Ventures USA LLC has announced an ...

One of the major contributors to complications in SCD is oxidative stress, a condition where the body’s antioxidant defense ...

Bone marrow transplantation (BMT) can potentially cure sickle cell disease, an inherited and painful blood disorder, but because of its potential drawbacks and costs, patients and caregivers often ...

National Workshop on ‘Sickle Cell and Thalassemia Elimination: Best Practices and Scalable Strategies’ was successfully held ...